Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.

Lorenzo CantiStéphanie Humblet-BaronIsabelle DesombereJulika NeumannPieter PannusLeo HeyndrickxAurélie HenrySophie ServaisEvelyne WillemsGrégory EhxStanislas GorielyLaurence SeidelJohan MichielsBetty WillemsAdrian ListonKevin K AriënYves BeguinMaria E GoossensArnaud MarchantFréderic Baron

Published in: Journal of hematology & oncology (2021)

The study was registered at clinicaltrialsregister.eu on 11 March 2021 (EudractCT # 2021-000673-83).

Keyphrases

hematopoietic stem cell
stem cell transplantation
bone marrow
low dose
dengue virus
high dose